Atrovent N

Atrovent N

ipratropium bromide

Manufacturer:

Boehringer Ingelheim

Distributor:

DKSH
Concise Prescribing Info
Contents
Ipratropium Br
Indications/Uses
Bronchodilator for maintenance treatment of bronchospasm associated w/ COPD, including chronic bronchitis, emphysema & asthma.
Dosage/Direction for Use
Adult & childn >6 yr Maintenance treatment 2 puff qds. Max total daily dose: 12 puff.
Contraindications
Hypersensitivity to atropine or its derivatives.
Special Precautions
Doses >160 drops daily in adult & adolescent >12 yr, & >80 drops daily in childn ≤12 yr. Immediately discontinue if paradoxical bronchospasm occurs. Patients predisposed to narrow-angle glaucoma. Pre-existing urinary outflow tract obstruction (eg, prostatic hyperplasia, bladder-neck obstruction); cystic fibrosis. Avoid contact w/ eyes. May affect the ability to drive & use machines. Pregnancy & lactation.
Adverse Reactions
Headache, throat irritation, cough, dry mouth, GI motility disorders (including constipation, diarrhoea & vomiting), nausea & dizziness.
Drug Interactions
Not recommended for chronic co-administration w/ other anti-cholinergics. Bronchodilatory effect may be intensified by β-adrenergics & xanthine prep.
MIMS Class
Antiasthmatic & COPD Preparations
ATC Classification
R03BB01 - ipratropium bromide ; Belongs to the class of other inhalants used in the treatment of obstructive airway diseases, anticholinergics.
Presentation/Packing
Form
Atrovent N MDI 20 mcg/puff
Packing/Price
(200 puffs/10 mL) 1's ($18.5/box)
Exclusive offer for doctors
Register for a MIMS account and receive free medical publications worth $139 a year.
Sign up for free
Already a member? Sign in